कोशिश गोल्ड - मुक्त
Japan's Ruling Party Seeks Leader with Trump Appeal
Mint Mumbai
|September 10, 2025
Relations with Washington Have Been Strained by Tariffs and US Calls for Japan and Others to Spend More on Defense
Among the questions facing ruling-party members who will choose Japan's likely next leader is who will get along best with President Trump. Would it be Sanae Takaichi, a conservative and adherent of former Prime Minister Shinzo Abe's expansive economic policies? Or Shinjiro Koizumi, a moderate but inexperienced member of a new generation of Japanese politicians who has the kind of energy and polish that Trump often likes?
Neither has formally declared their candidacy, but the pair are widely seen by analysts and lawmakers as the front-runners in a coming poll to select a new Liberal Democratic Party president. Whoever wins would need to be familiar to establishment parties in many Western democracies: Opt for a right-wing candidate who can bring disillusioned conservative voters back into the fold, or choose a more center-of-the-road leader who might be able to extend appeal in other directions.
Takaichi, who once dreamed of becoming a rock musician, is the figure who many in Abe's old faction within the LDP believe has a shot at winning back right-leaning voters. Upstart groups such as Sanseito have siphoned away some of those voters with promises to curb inflation and immigration.
यह कहानी Mint Mumbai के September 10, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Mumbai से और कहानियाँ
Mint Mumbai
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Mint Mumbai
EC extends electoral roll revision by a week to II Dec; final list on 14 Feb
The Election Commission on Sunday extended by one week the entire schedule of the ongoing special intensive revision (SIR) of electoral rolls in nine states and three Union territories amid allegations by opposition parties that the “tight timelines” were creating problems for people and ground-level poll officials.
2 mins
December 01, 2025
Mint Mumbai
THE PROBLEM IS NOT JUST ABOUT DYNASTIC POLITICS
These days Tejashvi Yadav is the target of intense trolling. Before him the Huda family in Haryana and Thackerays in Maharashtra got the same treatment. So, is the battle of victory and defeat in electoral politics a tussle between dynasts vs the rest? Absolutely not.
3 mins
December 01, 2025
Mint Mumbai
Green hydrogen: Fast fashion could help bump up demand
A boom in its use for clean synthetic inputs might make a difference
3 mins
December 01, 2025
Mint Mumbai
Let's be a bit more selective in using the word 'reforms'
Everybody should take a beat and think before uttering the word ‘reforms’ the next time. Glib usage, frequently in the wrong context, threatens to rob the word of its import.
3 mins
December 01, 2025
Mint Mumbai
As mid-cap alpha shrinks, should you consider passive strategies?
Advisers urge a balanced mix—add passives slowly and back strong, active managers, as mid-caps are still pricey
4 mins
December 01, 2025
Mint Mumbai
With $2.2 bn fund, ChrysCap has appetite for riskier bets
MD Saurabh Chatterjee details shift in global LP base, renewed focus on manufacturing
3 mins
December 01, 2025
Mint Mumbai
GDP growth of 8% plus: How to sustain this pace
Last quarter's economic expansion has cheered India but the challenge is to sustain a brisk rate for years to come. For private investment to chip in, revive infrastructure partnerships
2 mins
December 01, 2025
Mint Mumbai
INSIDE INDIA'S ATTEMPT TO TAME DEEPFAKES
Detection tools today are not universal or consistent across languages
5 mins
December 01, 2025
Mint Mumbai
APIs to innovation: Bulk drug makers ramp up CDMO bets
Once focused on low-margin active pharmaceutical ingredients (APIs), India’s bulk drug manufacturers are raising their ambitions, with several now investing heavily in research and development to win contract development and manufacturing work from global drugmakers.
2 mins
December 01, 2025
Listen
Translate
Change font size

